|Send to printer »|
GEN News Highlights : Mar 27, 2013
Tracking White Blood Cell Counts at Home
Engineers at the California Institute of Technology along with researchers at Jerusalem-based LeukoDx say they have developed a portable device to count leukocytes (white blood cells) that needs less than a pinprick’s worth of blood and takes only minutes to run. Currently, most leukocyte counts are performed with large-scale equipment in central clinical laboratories. If a physician collects blood samples from a patient in the office, usually requiring a full vial of blood for each test, it can take days to get the results. It looks like this could change.
“The white blood cell counts from our new system closely match the results from tests conducted in hospitals and other central clinical settings,” says Yu-Chong Tai, Ph.D., professor of electrical engineering and mechanical engineering at Caltech and the project’s principal investigator. “This could make point-of-care testing possible for the first time.”
When an infection or disease attacks the body, the immune system typically responds by sending more leukocytes into action. This means that checking the number of these cells is a relatively easy way to detect and monitor such conditions.
Portable leukocyte counters could improve outpatient monitoring of patients with chronic conditions such as leukemia or other cancers. The counters could be used in combination with telemedicine to bring medical care to remote areas. The devices could even enable astronauts to evaluate their long-term exposure to radiation while they are still in space, notes Dr. Tai. The researchers describe their work in the April 7 issue of Lab on a Chip.
“If we can give you a quick white blood cell count right in the doctor’s office,” adds Wendian Shi, a graduate student in Dr. Tai’s lab and lead author of the new paper, “you can know right away if you’re dealing with a viral infection or a bacterial infection, and the doctor can prescribe the right medication.”
The prototype device is able to count all five subtypes of leukocytes within a sample. It also provides an accurate differential of the four major subtypes—lymphocytes, monocytes, eosinophils, and neutrophils, explains Dr. Tai. In addition, it could be used to flag an abnormally high level of the fifth subtype, basophils, which are normally too rare (representing less than one percent of all leukocytes) for accurate detection in clinical tests, he points out.
The entire new system fits in a small suitcase (12” x 9” x 5”) and could easily be made into a handheld device, the engineers say.
A major development reported in the new paper is the creation of a detection assay that uses three dyes to stain leukocytes so that they emit light, or fluoresce, brightly in response to laser light. Blood samples are treated with this dye assay before measurement in the new device. The first dye binds strongly to the DNA found in the nucleus of leukocytes, making it simple to distinguish between white blood cells and the red blood cells that surround and outnumber them, according to Dr. Tai. The other two dyes help differentiate between the subtypes.
The heart of the new device is a 50-micrometer-long transparent channel made out of a silicone material with a cross section of only 32 micrometers by 28 micrometers. This is small enough to ensure that only one leukocyte at a time can flow through the detection region. The stained blood sample flows through this microfluidic channel to the detection region, where it is illuminated with a laser, causing it to fluoresce. The resulting emission of the sample is then split by a mirror into two beams, representing the green and red fluorescence.
Due to the assay, the leukocyte subtypes emit characteristic amounts of red and green light. Therefore, by determining the intensity of the emissions for each detected cell, the device can generate highly accurate differential white blood cell counts, reports Dr. Tai.
Shi says his ultimate goal is to develop a portable device that can help patients living with chronic diseases at home.
“For these patients, who struggle to find a balance between their treatment and their normal quality of life, we would like to offer a device that will help them monitor their conditions at home,” he explains. “It would be nice to limit the number of trips they need to make to the hospital for testing.”
© 2013 Genetic Engineering & Biotechnology News, All Rights Reserved